02.05.2014 • News • Nova Chemicals • People

Nova Chemicals CEO Woelfel Resigns Post

Randy Woelfel resigned as CEO of Canada's Nova Chemicals on May 1. His departure was announced shortly before the company's first-quarter earnings conference call.

In a statement the Canadian chemical producer said its board of directors and chief executive had been unable to agree on mutually satisfactory contract renewal terms and that the resignation was not due to differences of opinion about Nova's overall business strategy.

Todd Karran, the company's chief financial officer, has been appointed acting CEO to serve until a permanent chief executive has been found. Woelfel had headed Nova since 2009.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature